Literature DB >> 22783008

Calcium pyrophosphate dihydrate deposition in the trochanteric hip bursa presenting as acute hip pain.

Omer Salar1, Fizza Mushtaq, Mushtaq Ahmed.   

Abstract

Acute hip pain is a common reason for attendance to hospital. Immediate diagnoses include occult fractures, infectious and non-infectious inflammatory processes such as gout and pseudogout. Calcium pyrophosphate deposition disease (CPDD) is a rheumatological syndrome affecting articular cartilage and/or synovial fluid. It can occur as a clinical presentation (pseudogout) where calcium pyrophosphate dihydrate (CPPD) crystals are deposited within the joint space or radiographically, as chondrocalcinosis (CC), where CPPD crystals are deposited onto articular cartilages. Extraarticular manifestations of CPDD are rare. The authors report a case of CPPD deposition in the trochanteric bursa of a 35-year-old woman presenting as acute hip pain. The patient was treated successfully during arthroscopy with removal of the deposits and excision of the bursa. The patient remains well at 6 month follow-up.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22783008      PMCID: PMC3417024          DOI: 10.1136/bcr.12.2011.5426

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

Review 1.  Treating difficult crystal pyrophosphate dihydrate deposition disease.

Authors:  Nadia Announ; Pierre-André Guerne
Journal:  Curr Rheumatol Rep       Date:  2008-07       Impact factor: 4.592

2.  Monoarticular pseudogout of the hip: a case report.

Authors:  Kathleen E Brennan; Brian J McGrory
Journal:  Hosp Pract (1995)       Date:  2011-02

Review 3.  Calcium pyrophosphate and pseudogout.

Authors:  B Zarins; V K McInerney
Journal:  Arthroscopy       Date:  1985       Impact factor: 4.772

4.  Calcium pyrophosphate dihydrate (CPPD) crystal deposition in the trochanteric bursa of a patient with hip osteoarthritis.

Authors:  R Lagier; H Vasey
Journal:  J Rheumatol       Date:  1986-04       Impact factor: 4.666

Review 5.  An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease.

Authors:  Pascal Richette; Thomas Bardin; Michael Doherty
Journal:  Rheumatology (Oxford)       Date:  2009-04-27       Impact factor: 7.580

6.  Dexamethasone promotes calcium pyrophosphate dihydrate crystal formation by articular chondrocytes.

Authors:  Mark Fahey; Elizabeth Mitton; Emily Muth; Ann K Rosenthal
Journal:  J Rheumatol       Date:  2009-01       Impact factor: 4.666

Review 7.  Non-crystalline and crystalline rheumatic disorders in chronic kidney disease.

Authors:  Pasha Sarraf; Jonathan Kay; Anthony M Reginato
Journal:  Curr Rheumatol Rep       Date:  2008-07       Impact factor: 4.592

Review 8.  Crystal-induced arthritis: an overview.

Authors:  H R Schumacher
Journal:  Am J Med       Date:  1996-02-26       Impact factor: 4.965

Review 9.  Calcium pyrophosphate crystal deposition disease and other crystal deposition diseases.

Authors:  A G Fam
Journal:  Curr Opin Rheumatol       Date:  1992-08       Impact factor: 5.006

Review 10.  The young adult with hip pain: diagnosis and medical treatment, circa 2004.

Authors:  Orrin M Troum; John V Crues
Journal:  Clin Orthop Relat Res       Date:  2004-01       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.